Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

padeliporfin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Transitional Cell Cancer of Renal Pelvis and Ureter 1

Interventions

pembrolizumab 556 Specimen Handling 548 Magnetic Resonance Spectroscopy 456 Carboplatin 365 Cyclophosphamide 339 Biopsy 320 Cisplatin 304 Paclitaxel 271 Nivolumab 263 Radiotherapy 243 Gemcitabine 238 Bevacizumab 201 Dexamethasone 193 fludarabine 183 venetoclax 182 Oxaliplatin 163 Docetaxel 162 atezolizumab 158 durvalumab 157 Fluorouracil 156 Rituximab 150 Pemetrexed 149 Capecitabine 145 Doxorubicin 138 Radiation 133 Standard of Care 129 Lenalidomide 128 Prednisone 127 Drug Therapy 127 Radiosurgery 124

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04620239 2026-02-04

UCM301

Steba Biotech S.A.

Phase 3 Recruiting

Transitional Cell Cancer of Renal Pelvis and Ureter

Data powered by HemOnc (CC BY 4.0) Colophon ⚡